Browse
1,354 results
| ID | Drug | Indication | Area | Type | Benefit rating | Published |
|---|---|---|---|---|---|---|
| A26-51 | Nipocalimab | — | Head and nerves | Addendum | Not proven | 2026-06-18 |
| A25-160 | Nipocalimab | — | Head and nerves | Initial | Not proven | 2026-06-18 |
| A26-31 | Niraparib/abiraterone acetate | — | Cancer | Initial | Not proven | 2026-06-15 |
| A26-30 | imlunestrant | ER-positive, HER2-negative, locally advanced or metastatic breast cancer with activating ESR1 mutation, after prior endocrine therapy | Oncology | Initial | Not provenMinor | 2026-06-15 |
| A26-27 | Inebilizumab | — | Head and nerves | Initial | Not proven | 2026-06-15 |
| A26-26 | Inebilizumab | — | Immune system and infections | Initial | Not proven | 2026-06-15 |
| A26-25 | Mepolizumab | — | Airways and respiratory system | Initial | Not proven | 2026-06-15 |
| A26-45 | nivolumab | urothelial carcinoma, adjuvant treatment | Cancer | Addendum | MinorNot proven | 2026-06-05 |
| A26-44 | cemiplimab | cutaneous squamous cell carcinoma (adjuvant) | Cancer | Addendum | Not proven | 2026-06-05 |
| A26-43 | iptacopan | Paroxysmal nocturnal haemoglobinuria (PNH) with haemolytic anaemia | Haematology | Addendum | Not proven | 2026-06-05 |
| A25-156 | Iptacopan | — | Haematology | Initial | Not proven | 2026-06-05 |
| A25-155 | Cemiplimab | — | Cancer | Initial | Not proven | 2026-06-05 |
| A25-154 | Nivolumab | — | Cancer | Initial | MinorNot proven | 2026-06-05 |
| A25-140 | pirtobrutinib | Relapsed or refractory mantle cell lymphoma in adults previously treated with a Bruton tyrosine kinase (BTK) inhibitor | Oncology / Haematology | Initial | — | 2026-06-05 |
| A26-18 | Teprotumumab | — | Immune system and infections | Initial | Not proven | 2026-06-01 |
| A26-17 | Abemaciclib | — | Cancer | Initial | Not proven | 2026-06-01 |
| A26-16 | Colchicine | — | Heart and circulation | Initial | Non-quantifiable | 2026-06-01 |
| A26-15 | Donidalorsen | — | Immune system and infections | Initial | Considerable | 2026-06-01 |
| A26-14 | Tirzepatide | — | Digestion, metabolism and hormones | Initial | Not proven | 2026-06-01 |
| A26-13 | Gadopiclenol | — | Diagnostics | Initial | Not proven | 2026-06-01 |